EMD
EMYRIA LIMITED
$0.0470
▼ -6.00%
Market cap
$38M
Turnover
$178,643
Last price
$0.0470
Day change
-6.00%
Announcements
16
Range, past year
Open 0.058 · Low 0.023 · Now 0.047 · High 0.078
Open EMD in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
EMD momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
39/100
Wyckoff phase
Accumulation14d
Trend stage
Breakdown
1 Day
-6.0%
1 Week
-2.1%
1 Month
-2.1%
1 Year
-21.7%
RSI
48
Avg daily range
6.9%
EMYRIA LIMITED scores 39 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Accumulation, where it has been for 14 trading days. The weekly timeframe reads Accumulation, which agrees with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads moderate.
What stands out
- Volume 1.5× 60-day avg
Points to watch
- High volatility (ATR 6.9%)
- Risk rating: High
- Composite downside risk elevated
EMD announcements
Recent price-sensitive releases.
- 2026-09-10 FDA Selects EMD to Present at Psychedelic Medicines Hearing Progress Report
- 2026-09-08 Emyria Set to Launch First NSW Clinic Progress Report
- 2026-09-08 Emyria Year End Presentation for Investor Webinar Company Presentation
- 2026-08-31 Appendix 4E & Annual Financial Report Year End 30 June 2026 Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-08-20 Emyria Unlocks Treatment Capacity Progress Report
- 2026-07-29 June 2026 Quarterly Activities Report and Appendix 4C Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-06-24 Emyria Depression Program Shows Positive Results
More Health Care stocks
Most traded in the same sector.